NASDAQ WBA Walgreens Boots Alliance intraday: $11.98, 452,081,061.00 shares traded, liquidity insight
WBA stock is the intraday market focus as Walgreens Boots Alliance, Inc. (NASDAQ: WBA) trades at $11.98 with 452,081,061.00 shares changing hands on the United States market (USD). Trading activity is extreme versus the average volume of 16,940,296.00, pushing relative volume to 26.69 and making WBA one of the most active NASDAQ names this session. Investors are watching fundamentals and liquidity as price action holds near the 50-day average of $11.66 and well above the 200-day average of $10.81.
WBA stock intraday activity and market context
Walgreens Boots Alliance (WBA stock) is trading on NASDAQ in the United States at $11.98 with a small intraday rise of 0.50%. Volume at 452,081,061.00 versus average volume 16,940,296.00 signals heavy retail or block activity and a high liquidity window for large orders. Year range is $8.08 to $13.25, so current price sits near the upper quartile of the 52-week range.
WBA stock fundamentals and valuation
Fundamentals show mixed signals for WBA stock: EPS is -7.29 with a trailing PE of -1.64, book value per share is $8.46, and price-to-book is 1.44. Market cap stands at 10,369,421,068.00 USD, and debt-to-equity is elevated at 4.04, reflecting leverage. Free cash flow yield is modest at 5.59%, and current ratio is 0.60, which flags short-term liquidity pressure.
WBA stock technicals and trading signals
Technical indicators show strong intraday momentum for WBA stock: RSI reads 100.00 (overbought) and ADX is 50.00, indicating a strong trend. Key moving averages show price above the 50-day ($11.66) and 200-day ($10.81) averages. Keltner Channel bounds at 11.60–12.26 imply intraday volatility remains contained despite heavy volume.
WBA stock earnings, catalysts and outlook
Next earnings date is scheduled for 2025-06-25 11:00:00+00:00, a key catalyst for WBA stock. Recent revenue per share is 178.73 but net income per share is negative at -7.28, so investors will focus on margin improvement and guidance. Analyst activity currently shows a consensus tilt toward sell/hold, and Boots/retail macro trends will affect international segment performance.
WBA stock risks and opportunities
Risks for WBA stock include high leverage (debt-to-equity 4.04), negative EPS, and a low current ratio 0.60, which increases sensitivity to revenue shocks. Opportunities: stable retail pharmacy cash flows, potential margin fixes, and share-price recovery if operating cash flow improves. Trading liquidity today gives active investors a chance to reweight positions quickly.
Meyka AI rates WBA with a score out of 100 and forecast for WBA stock
Meyka AI rates WBA with a score out of 100: 58.04 (Grade C+), suggestion HOLD. This grade factors S&P 500 and sector comparison, financial growth, key metrics, analyst consensus and forecasts. Meyka AI’s forecast model projects $4.08 for the next year, implying -65.95% versus the current $11.98. Forecasts are model-based projections and not guarantees. Use the grade as one data point alongside earnings and cash flow trends.
Final Thoughts
WBA stock is the session’s standout by activity, trading at $11.98 on NASDAQ with 452,081,061.00 shares traded and relative volume 26.69, which creates a rare liquidity window for large investors. Fundamentals are mixed: trailing EPS -7.29, PE -1.64, price-to-book 1.44, and high leverage at debt-to-equity 4.04. Technicals show short-term strength but an overbought RSI 100.00. Analysts are cautious, and Meyka AI assigns a C+ (58.04) grade with a HOLD view. Meyka AI’s forecast projects $4.08, implying -65.95% versus today’s price; this models a conservative downside scenario. Scenario targets: a near-term bullish price target of $13.50 (+12.69%) and a bearish support target of $8.50 (-29.05%). These targets reflect year high/low context ($13.25 / $8.08) and should be weighed with the upcoming 2025-06-25 earnings report. For active traders the intraday liquidity is attractive; for longer-term investors, watch operating cash flow and leverage reduction before adding exposure. Meyka AI, an AI-powered market analysis platform, provides this data-driven snapshot but this is not financial advice.
FAQs
What is driving WBA stock’s heavy intraday volume today?
WBA stock volume is driven by a mix of block trades and heightened retail activity. Relative volume of 26.69 versus average volume 16,940,296.00 signals outsized order flow and high liquidity, often tied to news, options activity, or repositioning ahead of earnings.
How does Meyka AI grade affect the WBA stock view?
Meyka AI rates WBA 58.04 (Grade C+, HOLD). The grade blends benchmark, sector, growth, key metrics and analyst signals. Use it with fundamentals like EPS -7.29 and debt-to-equity 4.04, not as a sole buy or sell trigger.
What are realistic near-term price targets for WBA stock?
Scenario targets: a bullish near-term target of $13.50 (+12.69%) and a bearish support target of $8.50 (-29.05%). These reflect the 52-week range $8.08–$13.25 and current technical/fundamental mix.
When is the next earnings report for WBA stock and why it matters?
WBA earnings report is scheduled for 2025-06-25 11:00:00+00:00. Investors will watch margins, pharmacy volumes and guidance; a materially better operating cash flow could change the valuation and the Meyka AI outlook.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
